Germaine Escamea
Granada University School of Medicine, Spain
Biography
Germaine Escames has broad experience in the studies of the antioxidative role of melatonin and the identiï¬ cation of the mitochondria as the main target of melatonin and its anti-infl ammatory activity against the innate immune response, among others. From several years to date, her activity has been focused on the oncostatic activity of melatonin and the adverse eff ects of radio and chemotherapy. In addition, she studied the eff ects of melatonin on the skin. She has four international patents on melatonin. One is currently under a multicentric clinical trial (in 10 hospitals of Spain) for the prevention and healing of oral mucositis induced by radio and/or chemotherapy and other two patents consist in a endovenous melatonin formulation for the treatment of sepsis. The fourth patent consists in a regenerative and anti-aging cream of melatonin for its topic application in the skin. A clinical trial with this cream to treat position ulcers is now being carried out in collaboration with other groups.
Abstract
Abstract : Melatonin and skin